Shernan Holtan, Chief of Blood and Marrow Transplantation and Professor of Medicine at Roswell Park Comprehensive Cancer Center, shared a post on LinkedIn:
“Frequently heard from trainees: ‘I only want to do CAR T-cell therapy.’
This may stem from various reasons, including concerns about managing transplant late effects – which are, thankfully, becoming less common and severe as transplant platforms evolve.
Are we facing a mentorship gap in training the next generation to diagnose and manage chronic GVHD? What are your thoughts?
This illustration was generated with the help of OpenAI’s ChatGPT.”
More posts featuring Shernan Holtan.